Literature DB >> 16508749

A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women.

Alfredo Scillitani1, Carolyn Jang, Betty Y-L Wong, Geoffrey N Hendy, David E C Cole.   

Abstract

The parathyroid hormone type 1 receptor (PTHR1) mediates the actions of parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHRP). Interacting with this receptor, PTHRP contributes to skeletal development through the regulation of chondrocyte proliferation and differentiation. Recently, a tetranucleotide repeat-(AAAG)( n )-in the P3 promoter of the PTHR1 gene has been shown to have functional activity in vitro, and homozygosity for (AAAG)(6), or the 6/6 genotype, has been associated with greater adult height compared to the 5/5 genotype. In this study, we evaluated the association of (AAAG)( n ) with height and bone mineral density (BMD) measured at lumbar spine (LS) and femoral neck (FN) in a cohort of 677 young caucasian women 18-35 years of age. Genomic DNA was amplified and genotyped by comparison with sequenced controls following electrophoretic separation through high-resolution polyacrylamide gels. Allele frequencies for (AAAG)( n ) were: 76.8% (n=5); 20.9% (n=6); 1.8% (n=7); 0.18% (n=8); 0.27% (n=9); 0.08% (n=2), and there was no evidence for Hardy-Weinberg disequilibrium. Analysis of variance showed that subjects bearing one or two (AAAG)(6) alleles (6/X & 6/6) were significantly taller (165.7+/-0.5 cm) than the others (X/X, 164.5+/-0.3 cm; P=0.034). This association was significant after adjusting for multiple covariates-current age, age at menarche, physical activity, smoking status, and intakes of caffeine and calcium. Comparison of genotype groups for BMD was not significant at LS, but BMD was significantly higher at FN in the group with at least one (AAAG)(6) allele (adjusted means: 1.021+/-0.008 vs. 0.999+/-0.006 g/cm(2), P=0.032). In conclusion, our data show that subjects bearing one or two (AAAG)(6) alleles are taller than subjects without, reinforcing the notion that in vivo variation in promoter activity of the PTHR1 gene may be a relevant genetic influence on final adult height and BMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508749     DOI: 10.1007/s00439-006-0155-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height.

Authors:  J N Hirschhorn; C M Lindgren; M J Daly; A Kirby; S F Schaffner; N P Burtt; D Altshuler; A Parker; J D Rioux; J Platko; D Gaudet; T J Hudson; L C Groop; E S Lander
Journal:  Am J Hum Genet       Date:  2001-06-15       Impact factor: 11.025

Review 2.  The G protein-coupled receptors: pharmacogenetics and disease.

Authors:  Miles D Thompson; W McIntyre Burnham; David E C Cole
Journal:  Crit Rev Clin Lab Sci       Date:  2005       Impact factor: 6.250

3.  Tests of linkage and association of PTH/PTHrP receptor type 1 gene with bone mineral density and height in Caucasians.

Authors:  Yuan-Yuan Zhang; Peng-Yuan Liu; Yan Lu; Peng Xiao; Yong-Jun Liu; Ji-Rong Long; Hui Shen; Lan-Juan Zhao; Leo Elze; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  Weight and body mass index at menarche are associated with premenopausal bone mass.

Authors:  M Blum; S S Harris; A Must; S M Phillips; W M Rand; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

5.  Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.

Authors:  L A Rubin; G A Hawker; V D Peltekova; L J Fielding; R Ridout; D E Cole
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

6.  The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families.

Authors:  Shu-Feng Lei; Yan-Bo Wang; Man-Yuan Liu; Xiao-Yang Mo; Hong-Wen Deng
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

7.  Association between AAAG repeat polymorphism in the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene and adult height, urinary pyridinoline excretion, and promoter activity.

Authors:  Masanori Minagawa; Toshiyuki Yasuda; Tomoyuki Watanabe; Kanshi Minamitani; Yoshihito Takahashi; David Goltzman; John H White; Geoffrey N Hendy; Yoichi Kohno
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters.

Authors:  J D Bettoun; M Minagawa; G N Hendy; L C Alpert; C G Goodyer; D Goltzman; J H White
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Cloning of a parathyroid hormone/parathyroid hormone-related peptide receptor (PTHR) cDNA from a rat osteosarcoma (UMR 106) cell line: chromosomal assignment of the gene in the human, mouse, and rat genomes.

Authors:  Z Pausova; J Bourdon; D Clayton; M G Mattei; M F Seldin; N Janicic; M Rivière; J Szpirer; G Levan; C Szpirer
Journal:  Genomics       Date:  1994-03-01       Impact factor: 5.736

10.  Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes.

Authors:  Ji-Rong Long; Lan-Juan Zhao; Peng-Yuan Liu; Yan Lu; Volodymyr Dvornyk; Hui Shen; Yong-Jun Liu; Yuan-Yuan Zhang; Dong-Hai Xiong; Peng Xiao; Hong-Wen Deng
Journal:  BMC Genet       Date:  2004-05-24       Impact factor: 2.797

View more
  11 in total

1.  A long AAAG repeat allele in the 5' UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells.

Authors:  C L Galindo; J F McCormick; V J Bubb; D H Abid Alkadem; Long-Shan Li; L J McIver; A C George; D A Boothman; J P Quinn; M A Skinner; H R Garner
Journal:  Breast Cancer Res Treat       Date:  2010-12-10       Impact factor: 4.872

2.  Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass.

Authors:  John Pa Ioannidis; Mandy Y Ng; Pak C Sham; Elias Zintzaras; Cathryn M Lewis; Hong-Wen Deng; Michael J Econs; David Karasik; Marcella Devoto; Candace M Kammerer; Tim Spector; Toby Andrew; L Adrienne Cupples; Emma L Duncan; Tatiana Foroud; Douglas P Kiel; Daniel Koller; Bente Langdahl; Braxton D Mitchell; Munro Peacock; Robert Recker; Hui Shen; Katia Sol-Church; Loretta D Spotila; Andre G Uitterlinden; Scott G Wilson; Annie Wc Kung; Stuart H Ralston
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

Review 3.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

Review 4.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

Review 5.  Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing.

Authors:  Shahryar Noordin; Julie Glowacki
Journal:  Rheumatol Int       Date:  2015-07-21       Impact factor: 2.631

6.  Association between promoter region genetic variants of PTH SNPs and serum 25(OH)-vitamin D level.

Authors:  Nasser M Al-Daghri; Omar S Al-Attas; Soundararajan Krishnaswamy; Sobhy M Yakout; Abdul Khader Mohammed; Amal M Alenad; George P Chrousos; Majed S Alokail
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women.

Authors:  S Giroux; L Elfassihi; D E C Cole; F Rousseau
Journal:  Osteoporos Int       Date:  2008-04-17       Impact factor: 4.507

8.  Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Authors:  Thomas J Weber; James Koh; Samantha M Thomas; Joyce A Hogue; Randall P Scheri; Sanziana A Roman; Julie A Sosa
Journal:  Metabolism       Date:  2017-06-19       Impact factor: 8.694

9.  Epigenetic regulation of fetal bone development and placental transfer of nutrients: progress for osteoporosis.

Authors:  Georgeta Bocheva; Nadka Boyadjieva
Journal:  Interdiscip Toxicol       Date:  2011-12

10.  Common variants in FLNB/CRTAP, not ARHGEF3 at 3p, are associated with osteoporosis in southern Chinese women.

Authors:  G H Y Li; A W C Kung; Q-Y Huang
Journal:  Osteoporos Int       Date:  2009-09-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.